Get the Stockscreener App
1.82
2.15%
-0.04
Tiziana Life Sciences Ltd stock is traded at $1.82, with a volume of 90,677.
It is down -2.15% in the last 24 hours and down -7.61% over the past month.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
See More
Previous Close:
$1.86
Open:
$1.85
24h Volume:
90,677
Relative Volume:
0.24
Market Cap:
$211.49M
Revenue:
-
Net Income/Loss:
$-13.73M
P/E Ratio:
-14.00
EPS:
-0.13
Net Cash Flow:
$-3.92M
1W Performance:
-6.67%
1M Performance:
-7.61%
6M Performance:
+42.19%
1Y Performance:
+100.64%
1-Day Range:
$1.79
$1.85
1-Week Range:
$1.78
$1.96
52-Week Range:
$0.6295
$2.60
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
Name
Tiziana Life Sciences Ltd
Sector
Industry
Phone
-
Address
-
Compare TLSA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLSA
Tiziana Life Sciences Ltd
|
1.81 | 221.01M | 0 | -13.73M | -3.92M | -0.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.56 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.13 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.17 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.47 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.40 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-22-20 | Initiated | B. Riley Securities | Buy |
| Dec-17-18 | Initiated | Laidlaw | Buy |
Tiziana Life Sciences Ltd Stock (TLSA) Latest News
Is Tiziana Life Sciences Ltd stock a buy before product launchesGap Down & Weekly High Return Forecasts - newser.com
Is Tiziana Life Sciences Ltd stock entering bullish territoryMarket Weekly Review & Daily Growth Stock Investment Tips - newser.com
How Tiziana Life Sciences Ltd stock compares to industry benchmarksJuly 2025 Gainers & Free Safe Entry Trade Signal Reports - newser.com
How to use a screener to detect Tiziana Life Sciences Ltd breakoutsTrade Volume Report & Daily Technical Stock Forecast Reports - newser.com
Applying chart zones and confluence areas to Tiziana Life Sciences Ltd2025 Technical Overview & Low Volatility Stock Recommendations - newser.com
Analyzing recovery setups for Tiziana Life Sciences Ltd investorsQuarterly Profit Review & Expert Approved Momentum Ideas - newser.com
Will Tiziana Life Sciences Ltd stock recover faster than market2025 Risk Factors & Safe Capital Growth Trade Ideas - newser.com
Using portfolio simulators with Tiziana Life Sciences Ltd includedWeekly Investment Report & Verified Momentum Watchlists - newser.com
What technical signals suggest for Tiziana Life Sciences Ltd stockOptions Play & Advanced Swing Trade Entry Plans - newser.com
How Tiziana Life Sciences Ltd stock valuations compare to rivalsStop Loss & Accurate Trade Setup Notifications - newser.com
Is Tiziana Life Sciences Ltd stock recession proof2025 Investor Takeaways & Safe Investment Capital Preservation Plans - newser.com
Applying big data sentiment scoring on Tiziana Life Sciences LtdRate Cut & Verified Momentum Watchlists - newser.com
Can momentum traders help lift Tiziana Life Sciences LtdMarket Rally & Verified Momentum Stock Watchlist - newser.com
Can Tiziana Life Sciences Ltd stock outperform in 2025 bull marketSell Signal & Technical Analysis for Trade Confirmation - newser.com
Will a bounce in Tiziana Life Sciences Ltd offer an exit2025 Risk Factors & High Win Rate Trade Alerts - newser.com
How to manage a losing position in Tiziana Life Sciences Ltd2025 Bull vs Bear & High Return Trade Opportunity Guides - newser.com
Tiziana Life Sciences: Foralumab's Intranasal Push Is A Good Moonshot (NASDAQ:TLSA) - Seeking Alpha
Published on: 2025-10-31 05:15:32 - newser.com
Reversal indicators forming on Tiziana Life Sciences Ltd stockTrade Volume Report & Capital Efficiency Focused Strategies - newser.com
Has Tiziana Life Sciences Ltd found a price floorWeekly Profit Recap & AI Optimized Trade Strategies - newser.com
Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy - The Manila Times
Tiziana (Nasdaq: TLSA) to present at BIO-Europe on intranasal foralumab for na‑SPMS, MSA - Stock Titan
Tiziana Life Sciences Ltd Stock (TLSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):